Global Sleeping Pills research

Sleeping Pills Comprehensive Study by Type (Natural, Prescription, Over the counter), End users (Hospital, Pharmacy, Other), Distribution Channel (Online, Pharmacy) Players and Region - Global Market Outlook to 2030

Sleeping Pills Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled

Report Objectives / Segmentation Covered

By Type
  • Natural
  • Prescription
  • Over the counter
By End users
  • Hospital
  • Pharmacy
  • Other

By Distribution Channel
  • Online
  • Pharmacy

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of sleep disorders is fueling the market growth. There has been stressful working conditions which in turn is increasing the consumption of alcohol and tobacco. In addition, growing cases of sleeping disorder in old age, hence increasing old age population along with these factors are contributing towards the market growth
    • 3.3. Market Challenges
      • 3.3.1. Side effects caused by consumption of sleeping pill
    • 3.4. Market Trends
      • 3.4.1. Change in lifestyle of the consumers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sleeping Pills, by Type, End users, Distribution Channel and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Sleeping Pills (Value)
      • 5.2.1. Global Sleeping Pills by: Type (Value)
        • 5.2.1.1. Natural
        • 5.2.1.2. Prescription
        • 5.2.1.3. Over the counter
      • 5.2.2. Global Sleeping Pills by: End users (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Pharmacy
        • 5.2.2.3. Other
      • 5.2.3. Global Sleeping Pills by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Pharmacy
      • 5.2.4. Global Sleeping Pills Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Sleeping Pills: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanofi (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Takeda Pharmaceutical (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Apotex (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aurobindo Pharma (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Actellon Pharmaceuticals (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Allegiant Health (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cayman Chemical (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sunovion (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pharmacia & Upjohn (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Sleeping Pills Sale, by Type, End users, Distribution Channel and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Sleeping Pills (Value)
      • 7.2.1. Global Sleeping Pills by: Type (Value)
        • 7.2.1.1. Natural
        • 7.2.1.2. Prescription
        • 7.2.1.3. Over the counter
      • 7.2.2. Global Sleeping Pills by: End users (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Pharmacy
        • 7.2.2.3. Other
      • 7.2.3. Global Sleeping Pills by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Pharmacy
      • 7.2.4. Global Sleeping Pills Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sleeping Pills: by Type(USD Million)
  • Table 2. Sleeping Pills Natural , by Region USD Million (2018-2023)
  • Table 3. Sleeping Pills Prescription , by Region USD Million (2018-2023)
  • Table 4. Sleeping Pills Over the counter , by Region USD Million (2018-2023)
  • Table 5. Sleeping Pills: by End users(USD Million)
  • Table 6. Sleeping Pills Hospital , by Region USD Million (2018-2023)
  • Table 7. Sleeping Pills Pharmacy , by Region USD Million (2018-2023)
  • Table 8. Sleeping Pills Other , by Region USD Million (2018-2023)
  • Table 9. Sleeping Pills: by Distribution Channel(USD Million)
  • Table 10. Sleeping Pills Online , by Region USD Million (2018-2023)
  • Table 11. Sleeping Pills Pharmacy , by Region USD Million (2018-2023)
  • Table 12. South America Sleeping Pills, by Country USD Million (2018-2023)
  • Table 13. South America Sleeping Pills, by Type USD Million (2018-2023)
  • Table 14. South America Sleeping Pills, by End users USD Million (2018-2023)
  • Table 15. South America Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 16. Brazil Sleeping Pills, by Type USD Million (2018-2023)
  • Table 17. Brazil Sleeping Pills, by End users USD Million (2018-2023)
  • Table 18. Brazil Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 19. Argentina Sleeping Pills, by Type USD Million (2018-2023)
  • Table 20. Argentina Sleeping Pills, by End users USD Million (2018-2023)
  • Table 21. Argentina Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 22. Rest of South America Sleeping Pills, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Sleeping Pills, by End users USD Million (2018-2023)
  • Table 24. Rest of South America Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 25. Asia Pacific Sleeping Pills, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Sleeping Pills, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Sleeping Pills, by End users USD Million (2018-2023)
  • Table 28. Asia Pacific Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 29. China Sleeping Pills, by Type USD Million (2018-2023)
  • Table 30. China Sleeping Pills, by End users USD Million (2018-2023)
  • Table 31. China Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 32. Japan Sleeping Pills, by Type USD Million (2018-2023)
  • Table 33. Japan Sleeping Pills, by End users USD Million (2018-2023)
  • Table 34. Japan Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 35. India Sleeping Pills, by Type USD Million (2018-2023)
  • Table 36. India Sleeping Pills, by End users USD Million (2018-2023)
  • Table 37. India Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 38. South Korea Sleeping Pills, by Type USD Million (2018-2023)
  • Table 39. South Korea Sleeping Pills, by End users USD Million (2018-2023)
  • Table 40. South Korea Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 41. Taiwan Sleeping Pills, by Type USD Million (2018-2023)
  • Table 42. Taiwan Sleeping Pills, by End users USD Million (2018-2023)
  • Table 43. Taiwan Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 44. Australia Sleeping Pills, by Type USD Million (2018-2023)
  • Table 45. Australia Sleeping Pills, by End users USD Million (2018-2023)
  • Table 46. Australia Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Sleeping Pills, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Sleeping Pills, by End users USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 50. Europe Sleeping Pills, by Country USD Million (2018-2023)
  • Table 51. Europe Sleeping Pills, by Type USD Million (2018-2023)
  • Table 52. Europe Sleeping Pills, by End users USD Million (2018-2023)
  • Table 53. Europe Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 54. Germany Sleeping Pills, by Type USD Million (2018-2023)
  • Table 55. Germany Sleeping Pills, by End users USD Million (2018-2023)
  • Table 56. Germany Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 57. France Sleeping Pills, by Type USD Million (2018-2023)
  • Table 58. France Sleeping Pills, by End users USD Million (2018-2023)
  • Table 59. France Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 60. Italy Sleeping Pills, by Type USD Million (2018-2023)
  • Table 61. Italy Sleeping Pills, by End users USD Million (2018-2023)
  • Table 62. Italy Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 63. United Kingdom Sleeping Pills, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Sleeping Pills, by End users USD Million (2018-2023)
  • Table 65. United Kingdom Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 66. Netherlands Sleeping Pills, by Type USD Million (2018-2023)
  • Table 67. Netherlands Sleeping Pills, by End users USD Million (2018-2023)
  • Table 68. Netherlands Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 69. Rest of Europe Sleeping Pills, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Sleeping Pills, by End users USD Million (2018-2023)
  • Table 71. Rest of Europe Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 72. MEA Sleeping Pills, by Country USD Million (2018-2023)
  • Table 73. MEA Sleeping Pills, by Type USD Million (2018-2023)
  • Table 74. MEA Sleeping Pills, by End users USD Million (2018-2023)
  • Table 75. MEA Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 76. Middle East Sleeping Pills, by Type USD Million (2018-2023)
  • Table 77. Middle East Sleeping Pills, by End users USD Million (2018-2023)
  • Table 78. Middle East Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 79. Africa Sleeping Pills, by Type USD Million (2018-2023)
  • Table 80. Africa Sleeping Pills, by End users USD Million (2018-2023)
  • Table 81. Africa Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 82. North America Sleeping Pills, by Country USD Million (2018-2023)
  • Table 83. North America Sleeping Pills, by Type USD Million (2018-2023)
  • Table 84. North America Sleeping Pills, by End users USD Million (2018-2023)
  • Table 85. North America Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 86. United States Sleeping Pills, by Type USD Million (2018-2023)
  • Table 87. United States Sleeping Pills, by End users USD Million (2018-2023)
  • Table 88. United States Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 89. Canada Sleeping Pills, by Type USD Million (2018-2023)
  • Table 90. Canada Sleeping Pills, by End users USD Million (2018-2023)
  • Table 91. Canada Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 92. Mexico Sleeping Pills, by Type USD Million (2018-2023)
  • Table 93. Mexico Sleeping Pills, by End users USD Million (2018-2023)
  • Table 94. Mexico Sleeping Pills, by Distribution Channel USD Million (2018-2023)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Sleeping Pills: by Type(USD Million)
  • Table 106. Sleeping Pills Natural , by Region USD Million (2025-2030)
  • Table 107. Sleeping Pills Prescription , by Region USD Million (2025-2030)
  • Table 108. Sleeping Pills Over the counter , by Region USD Million (2025-2030)
  • Table 109. Sleeping Pills: by End users(USD Million)
  • Table 110. Sleeping Pills Hospital , by Region USD Million (2025-2030)
  • Table 111. Sleeping Pills Pharmacy , by Region USD Million (2025-2030)
  • Table 112. Sleeping Pills Other , by Region USD Million (2025-2030)
  • Table 113. Sleeping Pills: by Distribution Channel(USD Million)
  • Table 114. Sleeping Pills Online , by Region USD Million (2025-2030)
  • Table 115. Sleeping Pills Pharmacy , by Region USD Million (2025-2030)
  • Table 116. South America Sleeping Pills, by Country USD Million (2025-2030)
  • Table 117. South America Sleeping Pills, by Type USD Million (2025-2030)
  • Table 118. South America Sleeping Pills, by End users USD Million (2025-2030)
  • Table 119. South America Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 120. Brazil Sleeping Pills, by Type USD Million (2025-2030)
  • Table 121. Brazil Sleeping Pills, by End users USD Million (2025-2030)
  • Table 122. Brazil Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 123. Argentina Sleeping Pills, by Type USD Million (2025-2030)
  • Table 124. Argentina Sleeping Pills, by End users USD Million (2025-2030)
  • Table 125. Argentina Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 126. Rest of South America Sleeping Pills, by Type USD Million (2025-2030)
  • Table 127. Rest of South America Sleeping Pills, by End users USD Million (2025-2030)
  • Table 128. Rest of South America Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 129. Asia Pacific Sleeping Pills, by Country USD Million (2025-2030)
  • Table 130. Asia Pacific Sleeping Pills, by Type USD Million (2025-2030)
  • Table 131. Asia Pacific Sleeping Pills, by End users USD Million (2025-2030)
  • Table 132. Asia Pacific Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 133. China Sleeping Pills, by Type USD Million (2025-2030)
  • Table 134. China Sleeping Pills, by End users USD Million (2025-2030)
  • Table 135. China Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 136. Japan Sleeping Pills, by Type USD Million (2025-2030)
  • Table 137. Japan Sleeping Pills, by End users USD Million (2025-2030)
  • Table 138. Japan Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 139. India Sleeping Pills, by Type USD Million (2025-2030)
  • Table 140. India Sleeping Pills, by End users USD Million (2025-2030)
  • Table 141. India Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 142. South Korea Sleeping Pills, by Type USD Million (2025-2030)
  • Table 143. South Korea Sleeping Pills, by End users USD Million (2025-2030)
  • Table 144. South Korea Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 145. Taiwan Sleeping Pills, by Type USD Million (2025-2030)
  • Table 146. Taiwan Sleeping Pills, by End users USD Million (2025-2030)
  • Table 147. Taiwan Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 148. Australia Sleeping Pills, by Type USD Million (2025-2030)
  • Table 149. Australia Sleeping Pills, by End users USD Million (2025-2030)
  • Table 150. Australia Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Sleeping Pills, by Type USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Sleeping Pills, by End users USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 154. Europe Sleeping Pills, by Country USD Million (2025-2030)
  • Table 155. Europe Sleeping Pills, by Type USD Million (2025-2030)
  • Table 156. Europe Sleeping Pills, by End users USD Million (2025-2030)
  • Table 157. Europe Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 158. Germany Sleeping Pills, by Type USD Million (2025-2030)
  • Table 159. Germany Sleeping Pills, by End users USD Million (2025-2030)
  • Table 160. Germany Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 161. France Sleeping Pills, by Type USD Million (2025-2030)
  • Table 162. France Sleeping Pills, by End users USD Million (2025-2030)
  • Table 163. France Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 164. Italy Sleeping Pills, by Type USD Million (2025-2030)
  • Table 165. Italy Sleeping Pills, by End users USD Million (2025-2030)
  • Table 166. Italy Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 167. United Kingdom Sleeping Pills, by Type USD Million (2025-2030)
  • Table 168. United Kingdom Sleeping Pills, by End users USD Million (2025-2030)
  • Table 169. United Kingdom Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 170. Netherlands Sleeping Pills, by Type USD Million (2025-2030)
  • Table 171. Netherlands Sleeping Pills, by End users USD Million (2025-2030)
  • Table 172. Netherlands Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 173. Rest of Europe Sleeping Pills, by Type USD Million (2025-2030)
  • Table 174. Rest of Europe Sleeping Pills, by End users USD Million (2025-2030)
  • Table 175. Rest of Europe Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 176. MEA Sleeping Pills, by Country USD Million (2025-2030)
  • Table 177. MEA Sleeping Pills, by Type USD Million (2025-2030)
  • Table 178. MEA Sleeping Pills, by End users USD Million (2025-2030)
  • Table 179. MEA Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 180. Middle East Sleeping Pills, by Type USD Million (2025-2030)
  • Table 181. Middle East Sleeping Pills, by End users USD Million (2025-2030)
  • Table 182. Middle East Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 183. Africa Sleeping Pills, by Type USD Million (2025-2030)
  • Table 184. Africa Sleeping Pills, by End users USD Million (2025-2030)
  • Table 185. Africa Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 186. North America Sleeping Pills, by Country USD Million (2025-2030)
  • Table 187. North America Sleeping Pills, by Type USD Million (2025-2030)
  • Table 188. North America Sleeping Pills, by End users USD Million (2025-2030)
  • Table 189. North America Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 190. United States Sleeping Pills, by Type USD Million (2025-2030)
  • Table 191. United States Sleeping Pills, by End users USD Million (2025-2030)
  • Table 192. United States Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 193. Canada Sleeping Pills, by Type USD Million (2025-2030)
  • Table 194. Canada Sleeping Pills, by End users USD Million (2025-2030)
  • Table 195. Canada Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 196. Mexico Sleeping Pills, by Type USD Million (2025-2030)
  • Table 197. Mexico Sleeping Pills, by End users USD Million (2025-2030)
  • Table 198. Mexico Sleeping Pills, by Distribution Channel USD Million (2025-2030)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sleeping Pills: by Type USD Million (2018-2023)
  • Figure 5. Global Sleeping Pills: by End users USD Million (2018-2023)
  • Figure 6. Global Sleeping Pills: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America Sleeping Pills Share (%), by Country
  • Figure 8. Asia Pacific Sleeping Pills Share (%), by Country
  • Figure 9. Europe Sleeping Pills Share (%), by Country
  • Figure 10. MEA Sleeping Pills Share (%), by Country
  • Figure 11. North America Sleeping Pills Share (%), by Country
  • Figure 12. Global Sleeping Pills share by Players 2023 (%)
  • Figure 13. Global Sleeping Pills share by Players (Top 3) 2023(%)
  • Figure 14. Global Sleeping Pills share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 17. Sanofi (France) Revenue: by Geography 2023
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 20. Takeda Pharmaceutical (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Takeda Pharmaceutical (Japan) Revenue: by Geography 2023
  • Figure 22. Apotex (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Apotex (Canada) Revenue: by Geography 2023
  • Figure 24. Aurobindo Pharma (India) Revenue, Net Income and Gross profit
  • Figure 25. Aurobindo Pharma (India) Revenue: by Geography 2023
  • Figure 26. Actellon Pharmaceuticals (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Actellon Pharmaceuticals (Switzerland) Revenue: by Geography 2023
  • Figure 28. Allegiant Health (United States) Revenue, Net Income and Gross profit
  • Figure 29. Allegiant Health (United States) Revenue: by Geography 2023
  • Figure 30. Cayman Chemical (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cayman Chemical (United States) Revenue: by Geography 2023
  • Figure 32. Sunovion (United States) Revenue, Net Income and Gross profit
  • Figure 33. Sunovion (United States) Revenue: by Geography 2023
  • Figure 34. Pharmacia & Upjohn (United States) Revenue, Net Income and Gross profit
  • Figure 35. Pharmacia & Upjohn (United States) Revenue: by Geography 2023
  • Figure 36. Global Sleeping Pills: by Type USD Million (2025-2030)
  • Figure 37. Global Sleeping Pills: by End users USD Million (2025-2030)
  • Figure 38. Global Sleeping Pills: by Distribution Channel USD Million (2025-2030)
  • Figure 39. South America Sleeping Pills Share (%), by Country
  • Figure 40. Asia Pacific Sleeping Pills Share (%), by Country
  • Figure 41. Europe Sleeping Pills Share (%), by Country
  • Figure 42. MEA Sleeping Pills Share (%), by Country
  • Figure 43. North America Sleeping Pills Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sanofi (France)
  • Abbott Laboratories (United States)
  • Takeda Pharmaceutical (Japan)
  • Apotex (Canada)
  • Aurobindo Pharma (India)
  • Actellon Pharmaceuticals (Switzerland)
  • Allegiant Health (United States)
  • Cayman Chemical (United States)
  • Sunovion (United States)
  • Pharmacia & Upjohn (United States)
Additional players considered in the study are as follows:
Novel Laboratories Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 220 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Sleeping Pills research Quantitative research analysis
Global Sleeping Pills research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Sleeping Pills research Report?

Have a Query? Click Here

Other Related Reports

Aerosol Sprayhead Comprehensive Study by Type (Biodegradable, Non-Biodegradable), Application (Controlled Fluids, Control Liquid), Distribution Channel (Online, Offline), Product (Stationary Sprays, ...
$ 3350
Allergy Diagnostic Assay Kits Comprehensive Study by Type (In Vivo Tests, In Vitro Tests), Application (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), (), End User (Diagnostics...
$ 3450
Nimodipine Comprehensive Study by Application (Adults, Geriatric, Children (Greater Than 7 Years), Adolescents), Administration (Injection, Tablet, Capsules, Solutions, Others), Dosing (Hepatic Impai...
$ 3750
Depth Filtration Comprehensive Study by Type (Cartridge Filters, Capsule Filters, Filter Modules, Filter Sheets, Plates & Frames, Accessories, Others Products), Application (Final Product Processing ...
$ 3750
Human Micobiome Comprehensive Study by Type (Probiotics, Prebiotics, Foods, Medical Foods, Diagnostic Tests, Drugs, Others), Application (Therapeutics, Diagnostics, Others), Technology (Genomics, Pr...
$ 3650
Avanafil Comprehensive Study by Application (Young Age Patients, Old Age Patients), Forms (50 Mg Avanafil, 100 Mg Avanafil, 200 Mg Avanafil), Therapeutic Areas (Musculoskeletal, Nephrology, Rheumatol...
$ 3450